{"id":"https://openalex.org/W2166965664","doi":null,"title":"Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.","display_name":"Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.","publication_year":2015,"publication_date":"2015-11-01","ids":{"openalex":"https://openalex.org/W2166965664","mag":"2166965664","pmid":"https://pubmed.ncbi.nlm.nih.gov/26503994"},"language":"en","primary_location":{"id":"pmid:26503994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26503994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057847281","display_name":"Michael Stotz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Michael Stotz","raw_affiliation_strings":["Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047374036","display_name":"Armin Gerger","orcid":"https://orcid.org/0000-0002-3888-5401","observed_orcids":["https://orcid.org/0000-0002-3888-5401"]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Armin Gerger","raw_affiliation_strings":["Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084181856","display_name":"Johannes Haybaeck","orcid":"https://orcid.org/0000-0001-5518-3359","observed_orcids":["https://orcid.org/0000-0001-5518-3359"]},"institutions":[{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Johannes Haybaeck","raw_affiliation_strings":["Institute of Pathology, Medical University of Graz, Graz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pathology, Medical University of Graz, Graz, Austria","institution_ids":["https://openalex.org/I202276237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023411290","display_name":"Tobias Kiesslich","orcid":"https://orcid.org/0000-0001-5403-9478","observed_orcids":["https://orcid.org/0000-0001-5403-9478"]},"institutions":[{"id":"https://openalex.org/I27945538","display_name":"Paracelsus Medical University","ror":"https://ror.org/03z3mg085","country_code":"AT","type":"education","lineage":["https://openalex.org/I27945538"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Tobias Kiesslich","raw_affiliation_strings":["Department of Internal Medicine I, Institute of Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria Laboratory for Tumor Biology and Experimental Therapies, Institute of Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria","Paracelsus Medical University, Salzburg, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I, Institute of Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria Laboratory for Tumor Biology and Experimental Therapies, Institute of Physiology and Pathophysiology, Paracelsus Medical University, Salzburg, Austria","institution_ids":["https://openalex.org/I27945538"]},{"raw_affiliation_string":"Paracelsus Medical University, Salzburg, Austria","institution_ids":["https://openalex.org/I27945538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055819793","display_name":"Marc D. Bullock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc D Bullock","raw_affiliation_strings":["Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006483196","display_name":"Martin Pichler","orcid":"https://orcid.org/0000-0002-8701-9462","observed_orcids":["https://orcid.org/0000-0002-8701-9462"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I202276237","display_name":"Medical University of Graz","ror":"https://ror.org/02n0bts35","country_code":"AT","type":"education","lineage":["https://openalex.org/I202276237"]}],"countries":["AT","US"],"is_corresponding":false,"raw_author_name":"Martin Pichler","raw_affiliation_strings":["Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A. martin.pichler@medunigraz.at","1Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria","5Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A. martin.pichler@medunigraz.at","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I202276237"]},{"raw_affiliation_string":"1Division of Clinical Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria","institution_ids":["https://openalex.org/I202276237"]},{"raw_affiliation_string":"5Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.104,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.97369735,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"35","issue":"11","first_page":"5737","last_page":"44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":1.0},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8309999704360962},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.9919999837875366},{"id":"https://openalex.org/keywords/c-kit","display_name":"CD117","score":0.9599999785423279},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.7910000085830688},{"id":"https://openalex.org/keywords/systemic-chemotherapy","display_name":"systemic chemotherapy","score":0.5839999914169312},{"id":"https://openalex.org/keywords/radiofrequency-ablation","display_name":"radiofrequency ablation","score":0.7639999985694885},{"id":"https://openalex.org/keywords/transarterial-chemoembolization","display_name":"transarterial chemoembolization","score":0.9350000023841858},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9608393907546997},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8000558614730835},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7587293982505798},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.6556220054626465},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5701481103897095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48821118474006653},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4794832170009613},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4694000780582428},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.446557879447937},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43855294585227966}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:26503994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26503994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"pmh:oai:uni-augsburg.opus-bayern.de:102960","doi":null,"is_oa":false,"landing_page_url":"https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/102960","pdf_url":null,"source":{"id":"https://openalex.org/S4306400930","display_name":"OPUS (Augsburg University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I119916105","host_organization_name":"Augsburg University","host_organization_lineage":["https://openalex.org/I119916105"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"},{"id":"mag:2166965664","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26503994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1960641188","https://openalex.org/W1432656043","https://openalex.org/W2140016882","https://openalex.org/W2152899866","https://openalex.org/W2136121728","https://openalex.org/W3029536586","https://openalex.org/W341574833","https://openalex.org/W1189319653","https://openalex.org/W1124790770","https://openalex.org/W4296248299"],"abstract_inverted_index":{"Hepatocellular":[0],"carcinoma":[1],"(HCC)":[2],"is":[3,17],"an":[4,66,180],"aggressive":[5],"tumor":[6],"and":[7,24,40,42,54,63,96,101,178],"the":[8,18,136,141,167],"sixth":[9],"most":[10],"common":[11],"form":[12],"of":[13,107,170,174,182],"cancer":[14],"worldwide.":[15],"Surgery":[16],"gold-standard":[19],"treatment":[20,114],"for":[21,115,143,163],"local":[22],"disease":[23],"often":[25],"complemented":[26],"by":[27,80],"radiofrequency":[28],"ablation":[29],"or":[30],"transarterial":[31],"chemoembolization.":[32],"In":[33],"advanced":[34],"disease,":[35],"therapy":[36,47,162],"options":[37],"are":[38,44],"limited":[39],"relapse":[41],"metastasis":[43],"common.":[45],"Systemic":[46],"with":[48],"cytotoxic":[49],"drugs":[50],"such":[51],"as":[52],"doxorubicin":[53],"cisplatin":[55],"achieves":[56],"low":[57],"objective":[58],"response":[59],"rates":[60],"(typically":[61],"<10%)":[62],"even":[64],"sorafenib,":[65],"orally":[67],"administered":[68],"tyrosine":[69],"kinase":[70],"inhibitor":[71],"considered":[72],"a":[73,84,104],"breakthrough":[74],"when":[75],"introduced,":[76],"prolongs":[77],"median":[78],"survival":[79],"little":[81],"more":[82,131],"than":[83,133],"year.":[85],"Sorafenib":[86],"blocks":[87],"platelet-derived":[88],"growth":[89,93],"factor,":[90,94],"vascular":[91],"endothelial":[92],"c-KIT":[95],"rapidly":[97],"accelerated":[98],"fibrosarcoma":[99],"signaling,":[100],"belongs":[102],"to":[103,129,146],"new":[105],"class":[106],"targeted":[108,161],"drugs.":[109],"It":[110],"has":[111,126],"become":[112],"standard":[113],"advanced-stage":[116],"HCC":[117],"in":[118,135,159],"recent":[119,157],"years.":[120],"To":[121],"date,":[122],"no":[123],"other":[124],"agent":[125],"been":[127],"shown":[128],"be":[130],"effective":[132],"sorafenib":[134],"clinical":[137,150],"setting,":[138],"which":[139],"highlights":[140],"need":[142],"ongoing":[144],"research":[145],"address":[147],"this":[148],"important":[149],"challenge.":[151],"The":[152],"current":[153,168],"review":[154],"focuses":[155],"on":[156],"advances":[158],"molecular":[160],"HCC.":[164],"We":[165],"explore":[166],"status":[169],"evidence,":[171],"identify":[172],"areas":[173],"pressing":[175],"experimental":[176],"need,":[177],"provide":[179],"outline":[181],"promising":[183],"future":[184],"therapeutic":[185],"options.":[186]},"counts_by_year":[{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":11}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}